Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018, Queen’s Printer and Controller of HMSO. This work was produced by Brown et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 14 June 2018
  • Accepted: 8 February 2017
  • Published (online): 14 June 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Applied Health and Clinical Translation (Leeds)
?? Leeds.SU-LI54 ??
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Jun 2018 13:24
Last Modified: 07 Mar 2019 15:09
Status: Published
Publisher: NIHR Journals Library
Identification Number: https://doi.org/10.3310/hta22340

Share / Export

Statistics